Related Experiment Videos
Multielectrode microprobes for deep-brain stimulation fabricated with a customizable 3-D electroplating process.
1Department of Electrical Engineering, University of California, Los Angeles, Los Angeles, CA 90095, USA. pmotta@ieee.org
IEEE Transactions on Bio-Medical Engineering
|May 13, 2005
Summary
Researchers developed a novel micromachined probe for precise deep-brain stimulation (DBS) of the subthalamic nucleus in rats. This technology aims to minimize tissue damage for better Parkinson's disease research.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Medical Devices
Background:
- Deep-brain stimulation (DBS) alleviates Parkinson's disease symptoms but its mechanisms remain unclear.
- Current DBS methods lack precision and can cause tissue damage, hindering research.
- A need exists for advanced tools to study DBS in animal models.
Purpose of the Study:
- To design, fabricate, and test a novel micromachined probe for accurate and safe stimulation of the subthalamic nucleus (STN) in rats.
- To create a tool that minimizes tissue damage during deep-brain stimulation procedures.
- To facilitate comprehensive long-term studies of DBS for Parkinson's disease.
Main Methods:
- Designed and fabricated a novel micromachined probe with specific geometric and mechanical properties.
- Utilized gold coating and silicon nitride insulation for biocompatibility.
- Incorporated four platinum electrodes and a 3-D plating process for precise stimulation delivery.
Main Results:
- The novel probe demonstrated accurate positioning within the small and deep STN region of the rat brain.
- The probe's design effectively minimized damage to surrounding brain tissue.
- The biocompatible materials and electrode configuration allowed for controlled and spatially distributed stimulation.
Conclusions:
- The developed micromachined probe is a viable tool for precise STN stimulation in rats.
- This technology can advance research into the mechanisms of DBS for Parkinson's disease.
- Minimizing tissue damage with advanced probes is crucial for future DBS studies and therapeutic optimization.